We are monitoring the impact of COVID-19 on Latin America RIA Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3559
Share on
Share on

Latin America Radioimmunoassay Market Research Report – Segmented By Type, End User, Application & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3559
Pages: 145

Latin America RIA Market Size (2021 to 2026)

The size of the Latin America radioimmunoassay market was forecasted at USD 53.45 million in 2021. It is estimated to be growing at a CAGR of 3.97% and worth USD 64.94 million by 2026.

Radioimmunoassay (RIA) is an advanced and rapid technology for finding target molecules in various biological substances, paving the way for this technology in the research and development and diagnosis of various diseases, such as cancer. This technique is sensitive because it can cause cancer in the initial stage, treat peptic ulcers, extend neurotransmitters, fast detection of infections, precise identification of allergens in food, etc. In 2020, nearly 10 million deaths were recorded due to cancer and its complications across the globe. The number of cancer deaths worldwide is predicted to increase to 16.5 million by 2040. The most common type of cancer in 2020 was reported to be breast cancer, with around 49 prevalent cases per 100,000 population across the globe.

Among the various applications of RIA, there is increased adoption in the pharmaceutical industries, research laboratories, and contract-based research organizations (CROs), collaborations with medical institutions, has led to the growing demand for industrial and home-based kits. In addition, the increasing need for quality, error-free results to ensure patient satisfaction has led research laboratories and diagnostic centers to opt for high throughput automated procedures. It is also one of the significant factors which have driven the growth of the Latin America RIA market to a large extent.

RIA is also used in neurodegenerative disorders, infectious diseases for endocrine or hormone testing, and autoimmune disease testing. Factors such as increasing cancer incidence rate, sedentary lifestyle, use of processed food items, aging population, heavily polluted urbanization, and others are predicted to drive the market during the forecast period.

However, the use of hazardous, radioactive material in the immunoassay, the high cost of the equipment required for the procedure, and lack of complete reimbursement policies for the test are some of the factors predicted to limit the growth of the Latin American radioimmunoassay market.

This research report on the Latin America radioimmunoassay market has been segmented and sub-segmented into the following categories:

By Type: 

  • Reagents and Kits
  • Analyzers

By End User: 

  • Hospitals
  • Pharmaceutical Industry and CRO
  • Clinical Diagnostic Laboratories

By Application: 

  • Research
  • Clinical Diagnostics

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Based on the region, the Latin American region offers immense scope for development in the forecast years, as is evident from the region's high growth rate. Furthermore, despite a minor market share, the CAGR of the area is the second-highest globally, only behind Asia-Pacific. Therefore, this market shows promise during the forecast period.

Brazil held the largest share in the Latin America radioimmunoassay market in 2020 due to advances in medical research, clinical trials, high healthcare expenditure, and the growing senior population with chronic diseases. In 2019, health spending represented more than 9.6% of Brazil's gross domestic product (GDP), up from 9.48% the previous year. Moreover, government initiatives increased awareness among the population, and the growth of the medical tourism industry will provide great market growth opportunities in this region.

Mexico, followed by Bolivia and Argentina as the second and third largest markets, will dominate the Latin America radioimmunoassay market. The prevalence of infectious diseases, rapid growth in health infrastructure, increased spending by pharmaceutical industries on research and development to develop new products, and high expenditure in these regions is predicted to drive the overall Latin America radioimmunoassay market growth in the near future. For example, health spending in Bolivia accounted for over 6.4 percent of their GDP. In 2020, for the fourth year in a row, health spending in Mexico accounted for approximately 5.6% of its gross domestic product.

KEY MARKET PLAYERS:

Companies playing a significant role in the Latin America radioimmunoassay (ria) market profiled in the report is DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  2. Latin America Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Analyzers Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  5. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Pharmaceutical Industry and CRO Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Academics Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Clinical Diagnostic Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  10. Latin America Research Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  12. Brazil Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  13. Brazil Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  14. Brazil Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  15. Argentina Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  16. Argentina Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  17. Argentina Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  18. Mexico Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  19. Mexico Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  20. Mexico Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  21. Rest of Latin America Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  22. Rest of Latin America Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  23. Rest of Latin America Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample